The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 I, 1996, Pages 1831-1837

  Hasegawa, Naoki ^b   Kandra, Thomas G ^b   Husari, Ahmad W ^b   Veiss, Steve ^b   Hart, William T ^b   Hedgpeth, Joe ^b   Wydro, Robert ^b   Raffin, Thomas A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; IODINE 125; THROMBIN; THROMBOMODULIN;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; DRUG EFFECT; DRUG EFFICACY; ENDOTOXEMIA; ENTEROBACTER INFECTION; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

EID: 0030014232     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.6.8665042     Document Type: Article

References (38)

1. Bone, R. C. 1992. Modulators of coagulation. Arch. Intern. Med. 152:1381-1389.
2. Hasegawa, N., A. W. Husari, W. T. Hart, T. G. Kandra, and T. A. Raffin. 1994. Role of the coagulation system in ARDS. Chest 105: 268-277.
3. Fourrier, F., C. Chopin, J. Goudemand, S. Hendrycx, C. Caron, A. Rime, A. Marey, and P. Lestavel. 1992. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Chest 101:816-823.
4. Glauser, M. P., G. Zanetti, J.-D. Baumgartner, and J. Cohen. 1991. Septic shock: pathogenesis. Lancet 338:732-736.
5. Hoffmann, H., M. Siebeck, M. Spannagl, M. Weis, R. Geiger, M. Jochum, and H. Fritz. 1990. Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs. Am. Rev. Respir. Dis. 142:782-788.
6. Emerson, T. E., Jr., M. A. Fournel, W. J. Leach, and T. B. Redens. 1987. Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat. Circ. Shock 21:1-13.
7. Manwaring, D., D. Thorning, and P. W. Curreri. 1978. Mechanisms of acute pulmonary dysfunction induced by fibrinogen degradation product D. Surgery 84:45-54.
8. Minnear, F. L., D. Martin, L. Hill, A. E. Taylor, and A. B. Malik. 1987. Lung morphological and permeability changes induced by intravascular coagulation in dogs. Am. J. Physiol. 253:H634-H644.
9. Parkinson, J. F., N. U. Bang, and J. G. N. Garcia. 1993. Recombinant human thrombomodulin attenuates human endothelial cell activation by human thrombin. Arterioscler. Thromb. 13:1119-1123.
10. Ge, M., T. J. Ryan, H. Lum, and A. B. Malik. 1991. Fibrinogen degradation product fragment D increases endothelial monolayer permeability. Am. J. Physiol. 261:L283-L289.
11. Aderka, D. 1991. Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications. Isr. J. Med. Sci. 27:52-60.
12. Lentz, S. R., M. Tsiang, and E. J. Sadler. 1991. Regulation of thrombomodulin by tumor necrosis factor-α: comparison of transcriptional and posttranscriptional mechanisms. Blood 77:542-550.
13. van Hinsbergh, V. W. M., T. Kooistra, E. A. van den Berg, H. M. G. Princen, W. Fiers, and J. J. Emeis. 1988. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 72:1467-1473.
14. Moore, K. L., S. P. Andreoli, N. L. Esmon, C. T. Esmon, and N. U. Bang. 1987. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J. Clin. Invest. 79:124-130.
15. Semeraro, N., R. Triggiani, P. Montemurro, L. G. Cavallo, and M. Colucci. 1993. Enhanced endothelial tissue factor but normal thrombomodulin in endotoxin-treated rabbits. Thromb. Res. 71:479-486.
16. Quax, P. H. A., C. M. van den Hoogen, J. H. Verheijen, T. Padro, R. Zeheb, T. D. Gelehrter, T. J. C. van Berkel, J. Kuiper, and J. J. Emeis. 1990. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissue in vivo. J. Biol. Chem. 265:15560-15563.
17. Esmon, C. T., N. L. Esmon, and K. W. Harris. 1982. Complex formation between thrombin and thrombomodulin inhibits both thrombincatalyzed fibrin formation and factor V activation. J. Biol. Chem. 257:7944-7947.
18. Esmon, N. L., W. G. Owen, and C. T. Esmon. 1982. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J. Biol. Chem. 257:859-864.
19. Esmon, C. T. 1989. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264:4743-4746.
20. deFouw, N. J., Y. F. de Jong, F. Haverkate, and R. M. Bertina. 1988. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor: no evidence for a cofactor role of protein S. Thromb. Haemost. 60:328-333.
21. Mohri, M., M. Oka, Y. Aoki, Y. Gonda, S. Hirata, K. Gomi, T. Kiyota, T. Sugihara, S. Yamamoto, T. Ishida, and I. Maruyama. 1994. Intravenous extended infusion of recombinam human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats. Am. J. Hematol. 45:298-303.
22. Gonda, Y., S. Hirata, K. Saitoh, Y. Aoki, M. Mohri, K. Gomi, T. Sugihara, T. Kiyota, S. Yamamoto, T. Ishida, and I. Maruyama. 1993. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. Thromb. Res. 71:325-335.
23. Solis, M. M., M. Vitti, J. Cook, D. Young, C. Glaser, D. Light, J. Morser, R. Wydro, S. Yu, L. Fink, and J. F. Eidt. 1994. Recombinant soluble human thrombomodulin: a randomized, blinded assessment of prevention of venous thrombosis and effects on hemostatic parameters in a rat model. Thromb. Res. 73:385-394.
24. Aoki, Y., R. Ohishi, R. Takei, O. Matsuzaki, M. Mohri, K. Saitoh, K. Gomi, T. Sugihara, T. Kiyota, S. Yamamoto, T. Ishida, and I. Maruyama. 1994. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III. Thromb. Haemost. 71:452-455.
25. Opresko, L., H. S. Wiley, and R. A. Wallace. 1980. Proteins iodinated by the chloramine-T method appear to be degraded at an abnormally rapid rate after endocytosis. Proc. Natl. Acad. Sci. U.S.A. 77: 1556-1560.
26. Suzuki, Y., T. Tanigaki, D. Heimer, W. Wang, W. G. Ross, H. H. Sussman, and T. A. Raffin. 1992. Polyethylene glycol-conjugated superoxide dismutase attenuates septic lung injury in guinea pigs. Am. Rev. Respir. Dis. 145:388-393.
27. Clarke, J. H., D. R. Light, E. Blasko, J. F. Parkinson, M. Nagashima, K. McLean, L. Vilander, W. H. Andrews, J. Morser, and C. B. Glaser. 1993. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function, J. Biol. Chem. 268:6309-6315.
28. Witt, W., B. Maass, B. Baldus, M. Hildebrand, P. Donner, and W.-D. Schleuning. 1994. Coronary thrombosis with Desmodus salivary plasminogen activator in dogs. Circulation 90:421-426.
29. Busch, C., L. Rammer, and T. Saldeen. 1973. Quantitation of fibrin deposition and elimination in organs of rats injected with labelled fibrinogen and albumin. Thromb. Diathes. Haemorrh. 29:94-107.
30. Cerda, J., R. E. Urizar, R. Conran, F. A. Blumenstock, J. E. Kaplan, A. B. Malik, and R. Simon. 1986. Disseminated intravascular coagulation (DIC) induced by liquid (polyanetholsulfonate) in the rat. V. Effects on circulating fibronectin. Br. J. Exp. Pathol. 67:623-628.
31. Scheu, J. D., J. Shaoliang, E. Bruckner-Kardoss, P. E. Gargan, and M. Pollard. 1988. A model system for the in vivo determination of the thrombolytic effect of plasminogen activators. Thromb. Res. 51: 391-402.
32. Harada, H., A. Ishizaka, M. Yonemaru, A. A. Mallick, J. R. Hatherill, H. Zheng, C. M. Lilly, P. T. O'Hanley, and T: A. Raffin. 1989. The effects of aminophylline and pentoxifylline on multiple organ damage afterEscherichia coli sepsis. Am. Rev. Respir. Dis. 140:974-980.
33. Schaefer, C. F., D. J. Brackett, P. Tompkins, and M. F. Wilson. 1984. Anesthetic-induced changes in cardiovascular and small intestinal responses to endotoxin in the rat. Circ. Shock 12:125-133.
34. Matera, G., J. A. Cook, R. A. Hennigar, G. E. Tempel, W. C. Wise, T. D. Oglesby, and P. V. Halushka. 1988. Beneficial effects of a 5-lipoxygenase inhibitor in endotoxic shock in the rat. J. Pharmacol. Exp. Ther. 247:363-371.
35. van Deventer, S. J. H., H. R. Büller, J. W. ten Cate, L. A. Aarden, E. C. Hack, and A. Sturk. 1990. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520-2526.
36. Levi, M., H. ten Cate, K. A. Bauer, T. van der Poll, T. S. Edgington, H. R. Büller, S. J. H. van Deventer, C. E. Hack, J. W. ten Cate, and R. D. Rosenberg. 1994. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J. Clin. Invest. 93:114-120.
37. Taylor, F. B., Jr., A. Chang, C. T. Esmon, A. D'Angelo, S. Vigano-D'Angelo, and K. E. Blick. 1987. Protein C prevents the coagulation and lethal effects of Escherichia coli infusion in the baboon. J. Clin. Invest. 79:918-925.
38. Esmon, N. L., R. C. Carroll, and C. T. Esmon. 1983. Thrombomodulin blocks the ability of thrombin to activate platelets. J. Biol. Chem. 258:12238-12242.